"There are not a whole lot of patients that are able to do something like this, so we were doing it for them as well," says Chuck Wakefield. "It meant so much to them to have their names on the banner."
An essay from our Extraordinary Healers book honoring Elizabeth Ditavi, RN, BSN, OCN [Gillette Center for Gynecologic Oncology, Massachusetts General Hospital in Boston]
The breakthrough designation will expedite the development and review of this novel T-cell therapy in synovial sarcoma.
"This is what I've devoted my career to, and it is gratifying to see that really come to pass," says Robert Ferris.
The combination of Opdivo and radiation therapy may provide better disease control and a boost in overall survival in patients with melanoma whose disease has metastasized to the brain.
An essay from our Extraordinary Healers book honoring Sharon Bernico, RN, OCN [Oncology Therapy Center in Morris, Illinois].
The designation, which will expedite the development and review of sacituzumab govitecan in TNBC, is based on a phase 2 trial in which the therapy induced a response rate of 31 percent in heavily pretreated patients with metastatic TNBC.
Finalist for the 2015 Extraordinary Healer Award for Oncology Nursing: Elmeria S. Teffeteller, RN, MSN, APRN, AOCN, University of Tennessee Cancer Institute in Knoxville, Tennessee
"No recent cancer advance has been more transformative than immunotherapy," said ASCO president Julie M. Vose.